API 0.00% $1.53 australian pharmaceutical industries limited

bell potter rates her as a sell

  1. 56,554 Posts.
    lightbulb Created with Sketch. 259
    Tepid earnings growth, the mislaid $17.2m; cited that takeover rumours pushed her up recently; finally, they rate the stock as being "expensive". FYI.
 
watchlist Created with Sketch. Add API (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.